BionTech says "three doses" of vaccine neutralises Omicron variant

Özlem Türeci, BionTech's Chief Medical Officer says that the coronavirus vaccine developed jointly by BioNTech and Pfizer neutralises the Omicron variant of the virus after three doses. A laboratory study by its makers found "three doses of our vaccine neutralise the Omicron variant", but warned that "two doses show significantly reduce neutralization of this new variant.".